Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 09, 2012
Showing 1-1 of 1
Last Updated: 09/26/2026